Pharmaceutical manufacturers are under increasing pressure to meet the evolving requirements of EU GMP Annex 1 and to strengthen contamination control across every stage of sterile production. This video highlights how manufacturers are responding – and how West supports them with the high-quality components, technical guidance, and global processes needed to build a strong, inspection–ready Contamination Control Strategy (CCS).
Annex 1 is raising expectations around particulate control, cleanroom practices, and supplier collaboration. West helps manufacturers turn these expectations into practical improvements through data-driven insights, harmonized processes, and consistent component performance. With customers at the center, we work as an extension of their CCS to help mitigate risk and support delivery of safe, high-quality medicines worldwide.